Lataa...
Bevacizumab and other novel therapies for recurrent oligodendroglial tumors
Oligodendroglioma (WHO Grade 2) and anaplastic oligodendroglioma (WHO Grade 3) are glial tumors composed of neoplastic cellular elements that resemble oligodendrocytes. The treatment of recurrent, alkylator refractory oligodendroglial tumors is challenging given the paucity of effective treatment an...
Tallennettuna:
| Julkaisussa: | CNS Oncol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Future Medicine Ltd
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6082335/ https://ncbi.nlm.nih.gov/pubmed/26509217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.27 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|